Svai Sanford
2021
In 2021, Svai Sanford earned a total compensation of $4.7M as Chief Financial Officer at Rani Therapeutics Holdings, a 799% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $300,000 |
|---|---|
| Option Awards | $1,918,675 |
| Salary | $375,737 |
| Stock Awards | $2,077,272 |
| Total | $4,671,684 |
Sanford received $2.1M in stock awards, accounting for 44% of the total pay in 2021.
Sanford also received $300K in non-equity incentive plan, $1.9M in option awards and $375.7K in salary.
Rankings
In 2021, Svai Sanford's compensation ranked 2,832nd out of 12,415 executives tracked by ExecPay. In other words, Sanford earned more than 77.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,832 out of 12,415 | 77th |
Division Manufacturing | 1,128 out of 5,505 | 80th |
Major group Chemicals And Allied Products | 448 out of 2,375 | 81st |
Industry group Drugs | 392 out of 2,096 | 81st |
Industry Pharmaceutical Preparations | 262 out of 1,546 | 83rd |
Source: SEC filing on April 13, 2022.
Sanford's colleagues
We found three more compensation records of executives who worked with Svai Sanford at Rani Therapeutics Holdings in 2021.